Source: Annual Congress 2003 - The various appearance of resistance
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Richeldi, M. Losi, K. Ewer, D. M. Hansell, P. Roversi, L. M. Fabbri, A. Lalvani (Modena, Italy; Oxford, London, United Kingdom). Early diagnosis of sub-clinical multidrug-resistant tuberculosis. Eur Respir J 2003; 22: Suppl. 45, 3490

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis of COPD in patients with multidrug-resistant tuberculosis Source: International Congress 2018 – COPD around the world Year: 2018 Management and treatment of multidrug-resistant tuberculosis Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management Year: 2019 Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis Source: Eur Respir J 2010; 35: 338-342 Year: 2010 Comorbidome in multidrug-resistant tuberculosis patients Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Evaluation of treatment outcomes for multidrug-resistant tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001 Predictors of treatment outcome in multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 Recurrence after successful treatment among patients with multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011 The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Epidemiological features of nosocomial tuberculosis in patients with pulmonary tuberculosis in TB hospital Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009 PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence Source: Milan 2017 - Educational material Year: 2017 Treatment of drug-susceptible and drug-resistant tuberculosis Source: Eur Respir Monogr 2018; 82: 152-178 Year: 2018 Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal Source: Eur Respir J 2013; 42: 1747-1749 Year: 2013 Pulmonary tuberculosis relapse or atypical mycobacterium infection? Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Predicting Mycobacterium tuberculosis in patients with community-acquired pneumonia Source: Eur Respir J 2014; 43: 178-184 Year: 2004 Clinical diagnosis of tuberculosis Source: Eur Respir Monogr 2018; 82: 83-98 Year: 2018 Outcome of pulmonary multidrug-resistant tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 419s Year: 2007 Atypical manifestations of mycobacterium tuberculosis infection Source: Eur Respir J 2004; 24: Suppl. 48, 647s Year: 2004 The role of genexpert in the diagnosis of mycobacterium tuberculosis Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019